Patient Experience on a Hospital Oncology Service Before and After Implementation of a No-Visitor Policy During COVID-19.
Kenyon C BoltonMichael LawlerJennifer HauptmanMarissa MaddenStephen G DeVoeAmanda G KennedyBradley J TomkinsNaomi M HoddePublished in: Journal of patient experience (2021)
Hospital visitor restriction policies prompted by Coronavirus Disease 2019 (COVID-19) may lead to a less comfortable or informed inpatient experience for oncology patients admitted for non-COVID-19 conditions. We surveyed oncology inpatients before (n = 47) and after (n = 65) implementation of a no-visitor policy using a validated questionnaire to measure patient experience. Results revealed no significant difference in the percentage of patients reporting "no problems" (P < .05) in all questions. Patient experience was not adversely impacted by visitor restrictions enacted in response to COVID-19 on an oncology service, as measured by a questionnaire capturing common concerns among inpatients.
Keyphrases
- coronavirus disease
- healthcare
- mental health
- palliative care
- sars cov
- public health
- respiratory syndrome coronavirus
- end stage renal disease
- primary care
- chronic kidney disease
- adverse drug
- cross sectional
- patient reported
- acute care
- ejection fraction
- newly diagnosed
- emergency department
- quality improvement
- prognostic factors
- patient reported outcomes
- single cell
- electronic health record